SLC2A2 and type 2 diabetes mellitus: Guerra et al. described a reduced gene expression of SLC2A1, SLC2A2, and GCK (encoding glucokinase) in human T2D islets exhibiting a slight reduction in β-cell mass (~ 10%) [23].